Search Results

1-4 of 4 results for subject:Pfizer

Show detailed: On Off

Results: 10 20 50 100

Sort by: Newest first Oldest first

I am today updating Parliament on the work of the Vaccine Taskforce in securing a vaccine against Covid-19.

Tackling this virus is the biggest challenge that this country has faced in peacetime history. Today I am announcing the recent steps that the Vaccines Taskforce has taken towards making a successful...

Member

Lord Sharma (Conservative)

Department

Department for Business, Energy and Industrial Strategy

Type

Written statements

Date

20 July 2020

Reference

HCWS387

House

House of Commons

Business update

My Right Honourable friend the Secretary of State for Business, Energy and Industrial Strategy Alok Sharma has today made the following statement:

I am today updating Parliament on the work of the Vaccine Taskforce in securing a vaccine against Covid-19.

Tackling this virus is the biggest challenge that this country has...

Member

Lord Callanan (Conservative)

Department

Department for Business, Energy and Industrial Strategy

Type

Written statements

Date

20 July 2020

Reference

HLWS381

House

House of Lords

National Institute for Health and Clinical Excellence (NICE). Memoranda in the form of evidence laid before the Health Select Committee.

Type

House of Commons papers; Select Committee written evidence; Parliamentary committees

Committee

Health Committee

Notes

Report printed as HC 27 2007-08

Subjects

Assessments; Companies; Cost effectiveness; Finance; Licensing; Drugs; NHS; Medical treatments; Patients; Prescription drugs; Public expenditure; Primary care trusts; Prices; National Institute for Health and Care Excellence; Standards; Technology; British Medical Association; Pfizer; Alzheimer's Society; National Osteoporosis Society; Multiple Sclerosis Society; Clinical trials; Royal College of Nursing; Bioindustry Association; British Psychological Society; Cancer Research UK; Diabetes UK; Hepatitis C Trust; British Association for Counselling and Psychotherapy; Help the Aged; Motor Neurone Disease Association; Royal College of Midwives; Amgen Roche; Association of British Healthcare Industries; AstraZeneca; Arthritis and Musculoskeletal Alliance; Breakthrough Breast Cancer; Cancerbackup; Continence Foundation; Cystic Fibrosis Trust; JEC; Medical Technology Group; National Infertility Awareness Campaign; National Childbirth Trust; Myalgic Encephalomyelitis Association; National Rheumatoid Arthritis Society; Royal College of Paediatrics and Child Health; Roche; Sanofi-Aventis; Wyeth; Academy of Medical Sciences; Roy Castle Lung Cancer Foundation; Specialised Healthcare Alliance; Medtronic; American Pharmaceutical Group; Archimedes Pharma; Beat; Bayer Schering Pharma; British Society for Rheumatology; Bristol Myers Squibb Pharmaceuticals; Deltex Medical; Eli Lilly; European Medicines Group; Ethical Medicines Industry Group; FEmISA; Improving Surgical Outcomes Group; Institute for Innovation and Valuation in Health Care; Kidney Cancer UK; Kinetic Concepts; Leukaemia Care; Merck; Myeloma UK; Pelvic Pain Support Network; Rarer Cancers Forum; Royal College of Physicians of Edinburgh; Sirtex Medical; Servier Laboratories; 25% ME Group; Meads, Catherine; Bouder, Frederic; Barkham, Michael; Lofstedt, Ragnar; Simkin, Sandra; Austin, Daphne; Jones, Doris; Hooper, Malcolm; Chalmers, Iain; Hyde, Chris; Lee, Gay; Evans, Imogen; Marshall, Tom; Lee, Michael; Telford, Peter; Walsh, John; Syrett, Keith; Thornton, Hazel; Thomson, David; Woodward, Rose

Date

26 April 2007

Reference

HC 503 2006-07

House

House of Commons

Adjournment debate on diabetes

Adjournment debate on diabetes.

Lead member

David Amess

Answering member

Stephen Ladyman

Department

Department of Health

Type

Adjournment debates

Date

16 November 2004

Reference

426 c1327-34

House

House of Commons

Librarians' tools

Type

House

Session

Year

Department

Member

Primary member

Answering member

Legislative stage

Legislation

Subject

Publisher